MVC Capital, Inc. Announces Offering of Notes
Nov 06, 2017 21:06 pm UTC| Business
PURCHASE, N.Y., Nov. 06, 2017 -- MVC Capital, Inc. (NYSE:MVC) (the “Company”) announced the commencement of a registered public offering of senior notes (the “Notes”). The Notes are expected to be listed on the New...
KEMET Provides FY18 Third Quarter Guidance; Comments on Recent Trading Activity
Nov 06, 2017 21:06 pm UTC| Business
GREENVILLE, S.C., Nov. 06, 2017 -- KEMET Corporation (the “Company” or “KEMET”) (NYSE:KEM), a leading global supplier of passive electronic components, today confirmed its financial performance expectations for its...
Akcea Reports Financial Results and Highlights for Third Quarter 2017
Nov 06, 2017 21:06 pm UTC| Business
Submitted marketing authorization applications in the US, EU and Canada for volanesorsen in FCS Expanded leadership team to support global commercial launch of volanesorsen Conference Call Webcast Monday,...
Quantenna Announces Third Quarter 2017 Financial Results
Nov 06, 2017 21:06 pm UTC| Business
SAN JOSE, Calif., Nov. 06, 2017 -- Quantenna Communications, Inc. (NASDAQ:QTNA), a global leader and innovator of leading-edge performance Wi-Fi solutions, today announced preliminary unaudited financial results for the...
Tractor Supply Company Appoints Thomas A. Kingsbury to Its Board of Directors
Nov 06, 2017 21:06 pm UTC| Business
BRENTWOOD, Tenn., Nov. 06, 2017 -- Tractor Supply Company (NASDAQ:TSCO), the largest rural lifestyle retail store chain in the United States, today announced that Thomas A. Kingsbury has been appointed to the Company’s...
AppFolio, Inc. Announces Third Quarter 2017 Financial Results
Nov 06, 2017 21:06 pm UTC| Business
SANTA BARBARA, Calif., Nov. 06, 2017 -- AppFolio, Inc. (NASDAQ:APPF) ("AppFolio" or the "Company"), a leading provider of cloud-based business software solutions, today announced its financial results for the quarter...
Ultragenyx to Present at the Credit Suisse Healthcare Conference
Nov 06, 2017 21:06 pm UTC| Business
NOVATO, Calif., Nov. 06, 2017 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Emil D....